These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2846121)

  • 1. Paradoxical convulsant action of a novel non-competitive N-methyl-D-aspartate (NMDA) antagonist, tiletamine.
    Klockgether T; Turski L; Schwarz M; Sontag KH; Lehmann J
    Brain Res; 1988 Oct; 461(2):343-8. PubMed ID: 2846121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle relaxant and anticonvulsant activity of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-D-aspartate antagonist, in rodents.
    Turski L; Klockgether T; Sontag KH; Herrling PL; Watkins JC
    Neurosci Lett; 1987 Jan; 73(2):143-8. PubMed ID: 3029636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteic acid: convulsant action of stereoisomers in mice.
    Turski WA
    Brain Res; 1989 Feb; 479(2):371-3. PubMed ID: 2647211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant action of stereoisomers of gamma-glutamylaminomethylsulphonic acid in mice.
    Turski L; Meldrum BS; Jones AW; Watkins JC
    Eur J Pharmacol; 1985 May; 111(2):279-83. PubMed ID: 2990954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that antagonism at non-NMDA receptors results in anticonvulsant action.
    Turski L; Meldrum BS; Turski WA; Watkins JC
    Eur J Pharmacol; 1987 Apr; 136(1):69-73. PubMed ID: 3036544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants.
    Moreau JL; Pieri L; Prud'hon B
    Br J Pharmacol; 1989 Nov; 98(3):1050-4. PubMed ID: 2574061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus.
    Ganong AH; Cotman CW
    J Pharmacol Exp Ther; 1986 Jan; 236(1):293-9. PubMed ID: 2867215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant action of beta-kainic acid in mice. Is beta-kainic acid an N-methyl-D-aspartate antagonist?
    Turski L; Meldrum BS; Collins JF
    Brain Res; 1985 Jun; 336(1):162-6. PubMed ID: 2860949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kynurenic acid and AP5 distinguish between NMDA receptor agonists.
    Williams TL; Stone TW; Burton NR; Smith DA
    Exp Neurol; 1988 Dec; 102(3):366-7. PubMed ID: 2904376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.
    Lehmann J; Hutchison AJ; McPherson SE; Mondadori C; Schmutz M; Sinton CM; Tsai C; Murphy DE; Steel DJ; Williams M
    J Pharmacol Exp Ther; 1988 Jul; 246(1):65-75. PubMed ID: 2899170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
    Ferkany JW; Kyle DJ; Willets J; Rzeszotarski WJ; Guzewska ME; Ellenberger SR; Jones SM; Sacaan AI; Snell LD; Borosky S
    J Pharmacol Exp Ther; 1989 Jul; 250(1):100-9. PubMed ID: 2545856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning.
    Chiamulera C; Costa S; Reggiani A
    Psychopharmacology (Berl); 1990; 102(4):551-2. PubMed ID: 1982904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The action of quinolinate in the rat spinal cord in vitro.
    Magnuson DS; Peet MJ; Curry K; McLennan H
    Can J Physiol Pharmacol; 1987 Dec; 65(12):2483-7. PubMed ID: 2966665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextrorphan and levorphanol selectively block N-methyl-D-aspartate receptor-mediated neurotoxicity on cortical neurons.
    Choi DW; Peters S; Viseskul V
    J Pharmacol Exp Ther; 1987 Aug; 242(2):713-20. PubMed ID: 3039122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA antagonist properties of gamma-L-glutamyl-L-aspartate demonstrated on chemically induced seizures in mice.
    Mathis C; De Barry J; Ungerer A
    Eur J Pharmacol; 1990 Aug; 185(1):53-9. PubMed ID: 2146137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-competitive N-methyl-D-aspartate antagonists protect against sound-induced seizures in DBA/2 mice.
    Chapman AG; Meldrum BS
    Eur J Pharmacol; 1989 Jul; 166(2):201-11. PubMed ID: 2676564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex.
    Singh L; Oles RJ; Tricklebank MD
    Br J Pharmacol; 1990 Feb; 99(2):285-8. PubMed ID: 1691674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiletamine is a potent inhibitor of N-methyl-aspartate-induced depolarizations in rat hippocampus and striatum.
    ffRench-Mullen JM; Lehmann J; Bohacek R; Fisher RS
    J Pharmacol Exp Ther; 1987 Dec; 243(3):915-20. PubMed ID: 3320347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of felbamate and other compounds on N-methyl-D-aspartic acid-induced convulsions and lethality in mice.
    Sofia RD; Gordon R; Gels M; Diamantis W
    Pharmacol Res; 1994; 29(2):139-44. PubMed ID: 8058587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.